Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Genes and hormones cause hair loss, with four genes contributing equally.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Finasteride has a higher risk of reproductive side effects than minoxidil.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

No link found between new male baldness genes and female hair loss.